• EGCG Nanoparticle Radiosensitizers Enhance FLASH-RT Efficacy

  2026-05-21

  Xu et al. introduce self-assembled EGCG nanoparticles (BENPs) as radiosensitizers to improve the antitumor effect of ultra-high dose rate radiotherapy (FLASH-RT). Their findings demonstrate that BENPs amplify ROS generation, DNA damage, and positive immune modulation, suggesting a promising strategy for advancing cancer radioimmunotherapy.

• PreScission Protease (PSP): Reliable Tag Cleavage in Cell As

  2026-05-21

  This article addresses common laboratory challenges in protein purification and cell-based assay workflows, focusing on how PreScission Protease (PSP, SKU K1101) resolves issues of tag cleavage specificity, workflow reproducibility, and native protein recovery. Scenario-driven Q&A blocks, supported by experimental context and literature, provide actionable guidance for biomedical researchers and lab technicians evaluating protease options.

• PDHA1 Succinylation Drives Immune Evasion in Cholangiocarcin

  2026-05-20

  This study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma alters tumor cell metabolism, leading to immune suppression and chemoresistance. The findings highlight targeting PDHA1 succinylation as a novel strategy to overcome resistance to chemotherapy and improve antigen presentation in the tumor microenvironment.

• Reactive Oxygen Species Assay Kit: Advanced Workflows & Insi

  2026-05-20

  Unlock precise, quantitative ROS detection in live cells with the APExBIO Reactive Oxygen Species Assay Kit—empowering studies of oxidative stress, signaling, and cancer immunotherapy. Explore optimized protocols, real-world troubleshooting, and how emerging research on cuproptosis is reshaping applications for ROS quantification.

• ATM Kinase Inhibition: Translating DDR Modulation to the Cli

  2026-05-19

  This article delivers strategic guidance for translational researchers by integrating mechanistic insights on ATM kinase inhibition, with a focus on KU-55933, into the evolving landscape of DNA damage response (DDR) research and precision medicine. Drawing on recent advances and a landmark study on telomere-mitochondrial DNA crosstalk in heart failure, it charts new directions for targeting nuclear-mitochondrial signaling in disease modeling and drug discovery. Practical protocol parameters, competitive advantages, and a visionary outlook are provided for those aiming to harness ATM pathway modulation across disease domains.

• Eicosapentaenoic Acid: Mechanistic Leverage in Translational

  2026-05-19

  This thought-leadership article explores the mechanistic, experimental, and strategic dimensions of Eicosapentaenoic Acid (EPA), highlighting its value as an omega-3 fatty acid with cardiovascular and immunomodulatory relevance. We integrate new insights on prostaglandin pathways, bridge recent advances in humoral immunity, and provide actionable protocol guidance for translational researchers. The discussion positions APExBIO's high-purity EPA as a benchmark tool, while distinguishing this article through the integration of cross-domain evidence and future-facing recommendations.

• LY2109761: Precision TGF-β Receptor Inhibition in Fibrosis a

  2026-05-18

  Explore how LY2109761, a potent TGF-β receptor type I and II dual inhibitor, advances research in fibrosis and oncology. This article delivers mechanistic clarity, assay guidance, and unique insights for translational applications.

• Biomimetic Microparticles Target Tumor pH for Enhanced Thera

  2026-05-18

  This study introduces a biomimetic microparticle system that disrupts both intracellular and extracellular pH homeostasis in tumor cells through co-delivery of syrosingopine and a doxorubicin prodrug. The dual-action approach enhances chemo-immunotherapeutic efficacy by simultaneously promoting tumor cell death and restoring antitumor immune responses.

• Optimizing Reactive Oxygen Species Assay Kit Workflows in Ca

  2026-05-17

  Harness the power of APExBIO’s Reactive Oxygen Species Assay Kit for precision ROS quantification in live cells. This guide details advanced workflow refinements, troubleshooting strategies, and applied insights extending from nanomedicine to immunotherapy.

• N3-kethoxal: Unraveling RNA–Protein Interactions at Single-N

  2026-05-16

  Explore how N3-kethoxal, a membrane-permeable nucleic acid probe, enables single-nucleotide mapping of RNA–protein interactions and conformational dynamics. This article uniquely details its mechanistic advantages, protocol parameters, and practical insights for advanced nucleic acid research.

• N1-Methylpseudouridine Ensures Accurate Translation in mRNA

  2026-05-15

  Kim et al. (2022) provide robust evidence that N1-methylpseudouridine, a key modification in COVID-19 mRNA vaccines, preserves the fidelity of protein translation in cellular systems. Their findings alleviate concerns regarding miscoding or off-target effects, supporting the safe application of this modified nucleotide in mRNA therapeutic development.

• HyperPFU™ High-Fidelity DNA Polymerase: Technical Usage Guid

  2026-05-15

  HyperPFU™ high-fidelity DNA polymerase enables robust, accurate PCR amplification of long, GC-rich, or otherwise challenging DNA templates, outperforming standard enzymes in fidelity and processivity. It is best suited for workflows requiring blunt-ended, high-fidelity DNA products and should not be used in protocols that depend on 3'-A overhangs or sticky-end generation.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Technical Use

  2026-05-14

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) protects proteins from degradation by a broad spectrum of proteases during extraction and analysis, without interfering with divalent-cation dependent assays. It should not be used when metalloprotease inhibition via EDTA is required, and protocols must be adjusted for cell line sensitivity and workflow compatibility.

• Gap19: Selective Connexin 43 Hemichannel Blocker for Neuropr

  2026-05-14

  Gap19 stands out as a highly selective connexin 43 hemichannel blocker, enabling researchers to dissect neuroglial and immune signaling with unparalleled precision. Its unique peptide design empowers studies of neuroprotection in cerebral ischemia and inflammation, offering assay-ready reliability for ATP release inhibition and macrophage polarization workflows.

• Sisomicin: Mechanistic Precision for Translational Infection

  2026-05-13

  This article delivers a thought-leadership perspective on Sisomicin, the aminoglycoside antibiotic, blending mechanistic depth with practical strategy for translational researchers. It unpacks the scientific basis of Sisomicin’s inhibition of bacterial protein synthesis, addresses real-world experimental and clinical challenges, and differentiates its value within the competitive antibacterial landscape. Drawing from pivotal literature, in vitro/in vivo protocol insights, and APExBIO’s robust product intelligence, it provides strategic guidance for researchers seeking reproducibility and translational impact in Gram-negative and Gram-positive infection models.

483 records 3/33 page Previous Next 12345 下5页 Last page